DE69102211T3 - Pharmazeutische Zubereitung mit kontrollierter Freigabe. - Google Patents

Pharmazeutische Zubereitung mit kontrollierter Freigabe.

Info

Publication number
DE69102211T3
DE69102211T3 DE69102211T DE69102211T DE69102211T3 DE 69102211 T3 DE69102211 T3 DE 69102211T3 DE 69102211 T DE69102211 T DE 69102211T DE 69102211 T DE69102211 T DE 69102211T DE 69102211 T3 DE69102211 T3 DE 69102211T3
Authority
DE
Germany
Prior art keywords
controlled release
pharmaceutical preparation
water
medicinal compound
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69102211T
Other languages
English (en)
Other versions
DE69102211T2 (de
DE69102211D1 (de
Inventor
Kazuo Noda
Takashi Osawa
Masao Kobayashi
Shigeyuki Ishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26494375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69102211(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of DE69102211D1 publication Critical patent/DE69102211D1/de
Publication of DE69102211T2 publication Critical patent/DE69102211T2/de
Application granted granted Critical
Publication of DE69102211T3 publication Critical patent/DE69102211T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
DE69102211T 1990-06-28 1991-06-27 Pharmazeutische Zubereitung mit kontrollierter Freigabe. Expired - Lifetime DE69102211T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17176290 1990-06-28
SG4995A SG4995G (en) 1990-06-28 1995-01-13 Controlled release pharmaceutical preparation

Publications (3)

Publication Number Publication Date
DE69102211D1 DE69102211D1 (de) 1994-07-07
DE69102211T2 DE69102211T2 (de) 1994-09-15
DE69102211T3 true DE69102211T3 (de) 1997-08-28

Family

ID=26494375

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69102211T Expired - Lifetime DE69102211T3 (de) 1990-06-28 1991-06-27 Pharmazeutische Zubereitung mit kontrollierter Freigabe.

Country Status (17)

Country Link
US (1) US5137733A (de)
EP (1) EP0463877B2 (de)
JP (1) JP2558396B2 (de)
KR (1) KR0133511B1 (de)
CN (1) CN1040061C (de)
AT (1) ATE106241T1 (de)
CA (1) CA2045358C (de)
DE (1) DE69102211T3 (de)
DK (1) DK0463877T3 (de)
ES (1) ES2055962T5 (de)
FI (1) FI103476B (de)
GR (1) GR3024471T3 (de)
HK (1) HK33895A (de)
HU (1) HU214590B (de)
IE (1) IE64629B1 (de)
IL (1) IL98611A (de)
SG (1) SG4995G (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
CN1053808C (zh) * 1993-04-24 2000-06-28 章修纲 尼非地平控释剂型
JP2916978B2 (ja) * 1993-08-25 1999-07-05 エスエス製薬株式会社 放出開始制御型製剤
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
WO1999001111A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
CN1296417A (zh) 1998-02-10 2001-05-23 卫福有限公司 控释制剂
FR2778848B1 (fr) * 1998-05-20 2001-11-23 Prographarm Lab Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6270805B1 (en) 1998-11-06 2001-08-07 Andrx Pharmaceuticals, Inc. Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
US6039979A (en) * 1999-01-13 2000-03-21 Laboratoires Prographarm Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation
WO2000042998A1 (en) * 1999-01-21 2000-07-27 Elan Corporation, Plc Multiparticulate bisoprolol formulation
US6733789B1 (en) 1999-01-21 2004-05-11 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
AU784340B2 (en) 1999-12-23 2006-03-16 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
KR100523127B1 (ko) * 1999-12-23 2005-10-20 화이자 프로덕츠 인코포레이티드 하이드로겔계 약물 투여 형태
US20040185099A1 (en) * 2000-01-20 2004-09-23 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
US6620439B1 (en) * 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
US6984402B2 (en) 2000-10-03 2006-01-10 Elite Laboratories, Inc. Chrono delivery formulations and method of treating atrial fibrillation
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
WO2002094172A2 (en) * 2001-05-22 2002-11-28 Euro-Celtique Compartmentalized dosage form
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
US20030118652A1 (en) * 2001-11-15 2003-06-26 John Kelly Methods and compositions for use of (S)-bisoprolol
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US20050025824A1 (en) * 2001-12-14 2005-02-03 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
DE602004032525D1 (de) * 2003-03-11 2011-06-16 Seikagaku Kogyo Co Ltd Rstellungsverfahren dafür
KR101192722B1 (ko) 2003-04-24 2012-10-18 자고텍 아게 정해진 핵 위치를 가지는 서방성 정제
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
JP4722837B2 (ja) * 2004-05-07 2011-07-13 生化学工業株式会社 髄核充填剤
DE102004043863A1 (de) 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
AU2005313887B2 (en) * 2004-12-09 2011-10-27 Celgene Corporation Treatment using D-threo methylphenidate
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US8846100B2 (en) 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
MX2009001248A (es) 2006-08-03 2009-02-11 Nitec Pharma Ag Tratamiento con glucocorticoide de liberacion prolongada de enfermedad reumatoide.
JP2008024708A (ja) * 2007-08-20 2008-02-07 Euro-Celtique Sa アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
ES2602604T3 (es) * 2008-11-18 2017-02-21 Ucb Biopharma Sprl Formulaciones de liberación prolongada que comprenden un derivado de 2-oxo-1-pirrolidina
JP2010254691A (ja) * 2009-04-22 2010-11-11 Dr Suwelack Skin & Health Care Ag コーティングされた凍結乾燥成型品
CN108159019A (zh) 2009-12-02 2018-06-15 阿黛尔药物有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
PT2647648T (pt) * 2010-12-03 2017-10-02 Nippon Soda Co Forma de dosagem sólida que contém uma hidroxialquil celulose de baixa viscosidade
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
MX357551B (es) 2011-03-23 2018-07-13 Ironshore Pharmaceuticals & Dev Inc Metodos y composiciones para el tratamiento de trastorno por deficit de atencion.
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
JP5146859B2 (ja) * 2011-07-11 2013-02-20 ユーロ−セルティーク エス．エイ． アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944311A (ja) * 1982-09-07 1984-03-12 Santen Pharmaceut Co Ltd 徐放性顆粒およびその製造法
US5002776A (en) * 1983-12-22 1991-03-26 Elan Corporation, Plc Controlled absorption diltiazem formulations
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
US4559225A (en) * 1984-02-16 1985-12-17 Fourman Robert G Sunscreen composition
JPH0621066B2 (ja) * 1984-03-14 1994-03-23 杏林製薬株式会社 ３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
ATE79029T1 (de) * 1989-02-11 1992-08-15 Bayer Ag Arzneimittel mit kontrollierter wirkstoffabgabe.
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法

Also Published As

Publication number Publication date
ES2055962T5 (es) 1997-09-16
IE912166A1 (en) 1992-01-01
DK0463877T3 (da) 1994-06-27
FI103476B1 (fi) 1999-07-15
EP0463877B1 (de) 1994-06-01
AU7924391A (en) 1992-01-02
FI912952A (fi) 1991-12-29
AU634400B2 (en) 1993-02-18
JPH04235123A (ja) 1992-08-24
HUT59321A (en) 1992-05-28
HK33895A (en) 1995-03-17
HU214590B (hu) 1998-04-28
ES2055962T3 (es) 1994-09-01
SG4995G (en) 1995-06-16
DE69102211T2 (de) 1994-09-15
KR920000313A (ko) 1992-01-29
DE69102211D1 (de) 1994-07-07
HU912170D0 (en) 1991-12-30
US5137733A (en) 1992-08-11
EP0463877B2 (de) 1997-07-02
IE64629B1 (en) 1995-08-23
GR3024471T3 (en) 1997-11-28
EP0463877A1 (de) 1992-01-02
IL98611A (en) 1998-10-30
FI912952A0 (fi) 1991-06-18
CN1058533A (zh) 1992-02-12
IL98611A0 (en) 1992-07-15
CA2045358A1 (en) 1991-12-29
KR0133511B1 (ko) 1998-04-23
FI103476B (fi) 1999-07-15
CN1040061C (zh) 1998-10-07
CA2045358C (en) 1998-04-28
JP2558396B2 (ja) 1996-11-27
ATE106241T1 (de) 1994-06-15

Similar Documents

Publication Publication Date Title
DE69102211D1 (de) Pharmazeutische Zubereitung mit kontrollierter Freigabe.
DE69002604T2 (de) Pharmazeutische Zubereitung mit verzögerter Freisetzung und seine Herstellung.
ATE67408T1 (de) Arzneimittel mit verzoegerter freigabe in oraler dosisform.
DE69121465D1 (de) Mit Polyäthylenimin in-line beschichteter Polymerfilm
ATE53490T1 (de) Arzneipraeparate mit geregelter wirkstoffabgabe.
DE3865631D1 (de) Darreichungsform mit kontrollierter freigabe.
MX9100188A (es) Articulo absorbente teniendo una capa moduladora de flujo hidrofilica
DE3855852T2 (de) Kugelförmige Granula mit Kern sowie deren Herstellung
CA2304110A1 (en) Theophylline sustained release tablet
DE69624047D1 (de) Im unteren Teil des Verdauungstrakts freisetzende pharmazeutische Zubereitung in Form einer beschichteten Kapsel
DE69435145D1 (de) Formulierungen mit kontrollierter Abgabe überzogen mit wässrigen Dispersionen von Ethylcellulose
EP0387751A3 (de) Arzneimittel enthaltendes Heftpflaster
SE8803822A (de)
ES2177831T3 (es) Articulos absorbentes que tienen angulos de contacto con el fluido y capa posterior con aberturas.
DE3889711T2 (de) Oberflächenbehandlung eines PET-Filmes.
DE69105595D1 (de) Vorrichtung versehen mit einer photorefraktiven polymeren Dünnschicht zur Behandlung von dynamischen Hologrammen.
IL100529A0 (en) Chiral polymers,their preparation and their application in the preparation of optically active 2-arylpropionic acids
CA2124425A1 (en) Pharmaceutical Tablets Releasing the Active Substance After a Definite Period of Time
KR900018553U (ko) 물 전사에 의한 무늬층과 투명 코팅 피막층을 갖는 합성수지 제품

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings